Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Neurovascular Thrombectomy Devices Market Report Overview
The Neurovascular Thrombectomy Devices market size was $872.5 million in 2023. Factors such as constant revision of protocol and best practice guidelines will drive the market growth at a CAGR of more than 8% from 2023 to 2033.
Neurovascular Thrombectomy Devices are used to remove blood clots in the neurovascular vessels during an acute ischemic stroke. In general, the incidence rate of ischemic strokes is likely to increase over the forecast period due to population growth, high aging population, and improvements in diagnostic techniques and facilities.
Neurovascular Thrombectomy Devices Market Outlook, 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Neurovascular Thrombectomy Devices Market Forecast
Download A Free Report Sample
The neurovascular thrombectomy devices market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the neurovascular thrombectomy devices market for 2020 and beyond. Furthermore, the report provides neurovascular thrombectomy devices market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $872.5 million |
CAGR (2023-2033) | >8% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2023 |
Key Segments | · Aspiration Catheters
· Stent Retrievers |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Leading Companies | · Medtronic Plc
· Stryker Corp · Cerenovus · Penumbra Inc · MicroVention Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Neurovascular Thrombectomy Devices Market Segments
The key segments of the neurovascular thrombectomy devices market are Aspiration Catheters and Stent Retrievers. Stent Retrievers led the neurovascular thrombectomy devices market in 2023. They are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached. One unit refers to one stent retriever.
An aspiration catheter is a micro-vacuum that is fed into affected vessels to remove large vessel occlusions during an acute ischemic stroke. One unit refers to one aspiration catheter.
Neurovascular Thrombectomy Devices Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights into the Neurovascular Thrombectomy Devices Market Segment
Regional Analysis of Neurovascular Thrombectomy Devices Market
The key regions in the Neurovascular Thrombectomy Devices market are North America, Europe, Asia-Pacific, South Central America, and the Middle East and Africa. North America dominated the market in 2023.
The number of thrombectomy procedures in North America will grow during the forecast period. It is evident that thrombectomy procedures, in combination with t-PA, are extremely effective in treating acute ischemic strokes. Additionally, the procedures using aspiration catheter devices will experience a higher growth rate since these are quicker compared to stent retriever procedures.
Neurovascular Thrombectomy Devices Market Analysis by Regions, 2023 (%)
Buy the Full Report to Know More about the Regions in the Neurovascular Thrombectomy Devices Market
Neurovascular Thrombectomy Devices Market - Competitive Landscape
In 2023, Medtronic’s neurovascular thrombectomy devices market share was the highest
The major players in the neurovascular thrombectomy devices market are:
- Medtronic Plc
- Stryker Corp
- Cerenovus
- Penumbra Inc
- MicroVention Inc
The key strategies that major companies follow are entering the market with new and innovative devices, they make great acquisition targets. Generally, a broad portfolio of products is a way to develop expertise within the space and a solid position in the market. Companies with a broad portfolio will benefit from this.
Companies that were previously limited to the stent retrievers market have also expanded their portfolio into the aspiration catheter device market.
Neurovascular Thrombectomy Devices Market Analysis by Companies, 2023 (%)
Buy the Full Report for more Company-Wise Insights into the Neurovascular Thrombectomy Devices Market
Neurovascular Thrombectomy Devices Market Dynamics
Drivers: The key factors positively impacting the neurovascular thrombectomy devices market were constant revision of protocol and best practice guidelines to ensure patients can receive timely treatment. Also, reimbursement of devices will support the market growth.
Barriers: Factors such as the Lack of trained specialists available 24 hours to perform neurovascular thrombectomy procedures may affect the demand for the neurovascular thrombectomy devices market. Also, an insufficient number of INR facilities will negatively impact neurovascular thrombectomy devices market growth.
Future Outlook: Factors that may limit growth, advancements in protocol, technology, and logistics are constantly being revisited in each country. This will help to overcome the challenges and provide better care for stroke patients.
Segments Covered in the Report
Neurovascular Thrombectomy Devices Segments Outlook (Value, $ Million, 2015-2033)
- Aspiration Catheters
- Stent Retrievers
Neurovascular Thrombectomy Devices Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions
- The neurovascular thrombectomy devices market research report includes an insightful review of the key industry trends.
- The neurovascular thrombectomy devices market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, Country, and Global Infusion Pumps Market Insights:
- The neurovascular thrombectomy devices market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- The neurovascular thrombectomy devices market SWOT analysis.
- The report provides trends and Infusion Pumps market competitive dynamics.
Buy the Full Report for More Insights on the neurovascular thrombectomy devices market share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. Also, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered – Cerenovus, Medtronic Plc, Phenox GmbH, MicroVention Inc, Stryker Corp, Imperative Care Inc, Rapid Medical, Penumbra Inc, Balt SAS, Acandis GmbH & Co KG and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the infusion pump market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the neurovascular thrombectomy devices market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on the neurovascular thrombectomy devices market.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving neurovascular thrombectomy devices.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of neurovascular thrombectomy devices market share by company. Identify strong competitors and create winning strategies to stand out in the global neurovascular thrombectomy devices market.
- Track regional neurovascular thrombectomy devices market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global neurovascular thrombectomy devices market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
Medtronic Plc
Phenox GmbH
MicroVention Inc
Stryker Corp
Imperative Care Inc
Rapid Medical
Penumbra Inc
Balt SAS
Acandis GmbH & Co KG
Others
Frequently asked questions
-
What was the Neurovascular Thrombectomy Devices market size in 2023?
The Neurovascular Thrombectomy Devices market size was $872.5 million in 2023.
-
Which region held the largest share of the Neurovascular Thrombectomy Devices market in 2023?
North America held the largest Neurovascular Thrombectomy Devices market share in 2023.
-
Which segment held the largest share of the Neurovascular Thrombectomy Devices market in 2023?
Stent Retrievers led the Neurovascular Thrombectomy Devices market in 2023.
-
Which are the major players operating in the Neurovascular Thrombectomy Devices market?
Some of the leading companies in the Neurovascular Thrombectomy Devices market are Cerenovus, Medtronic Plc, Phenox GmbH, MicroVention Inc, Stryker Corp, Imperative Care Inc, Rapid Medical, Penumbra Inc, Balt SAS, and Acandis GmbH & Co KG.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.